Evidence map›Paper›PMID 28191450›Full record

ArticleNanotheranostics2017

Remotely Triggered Nano-Theranostics For Cancer Applications.

Alexandra Sneider, Derek VanDyke, Shailee Paliwal, Prakash Rai

Open access · hybridAbstract read
In one paragraph

Article in Nanotheranostics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Review
  3. Advanced biomedical research · 2025
    Article
  4. Review
  5. Timing and Mechanisms of Nanodiamond Uptake in Colon Cancer Cells.Nanotechnology, science and applications · 2024
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. A NovelLife (Basel, Switzerland) · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Smart Nanotheranostics Responsive to Pathological Stimuli.Frontiers in bioengineering and biotechnology · 2020
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Clinical Trials of Thermosensitive Nanomaterials: An Overview.Nanomaterials (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alexandra SneiderUniversity of Massachusetts Lowell, Department of Chemical Engineering, Francis College of Engineering, 1 University Ave, Lowell, MA 01854, USA.
Derek VanDykeUniversity of Massachusetts Lowell, Department of Chemical Engineering, Francis College of Engineering, 1 University Ave, Lowell, MA 01854, USA.
Shailee PaliwalUniversity of Massachusetts Lowell, Department of Chemical Engineering, Francis College of Engineering, 1 University Ave, Lowell, MA 01854, USA.
Prakash RaiUniversity of Massachusetts Lowell, Department of Chemical Engineering, Francis College of Engineering, 1 University Ave, Lowell, MA 01854, USA.
University of Massachusetts Lowell · US

Funding

Theranostic Nanomedicine for Breast Cancer Prevention and Image-Guided TherapyR00CA153948 · NCI · UNIVERSITY OF MASSACHUSETTS LOWELL · PI RAI, PRAKASH R · 2012 to 2014
$704k
Theranostic Nanomedicine for Breast Cancer Prevention and Image-Guided TherapyK99CA153948 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI RAI, PRAKASH R · 2010 to 2011
$245k
NCI NIH HHS K99 CA153948NCI NIH HHS R00 CA153948
6 · The paper itself

Abstract

Nanotechnology has enabled the development of smart theranostic platforms that can concurrently diagnose disease, start primary treatment, monitor response, and, if required, initiate secondary treatments. Recent

Indexed as

externally-triggeredimage guidednanomedicineoncologyphotoactivated

Identifiers

PMID28191450
PMCPMC5298883
OpenAlexW2564285545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.